Alcon AG

Alcon is a healthcare company with a brilliant vision. This healthcare manufacturer develops and sells products for all types of eye conditions. Being a global leader in vision healthcare, Alcon holds bragging rights as the largest eye care device company in the world. Their products and services are offered in 140 out of 195 countries in the world.

$94.66
(as of Sep 6, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Alcon AG

Stock Price
$94.66
Ticker Symbol
ALC
Exchange
NYSE

Industry Information for Alcon AG

Sector
Healthcare
Industry
Medical Instruments & Supplies

Company Description for Alcon AG

Country
USA
Full Time Employees
25,000

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Fundamentals for Alcon AG

Market Capitalization
$46,690,480,128
EBITDA
$2,315,000,064
Dividends per Share
$0.29
P/E Ratio
42.64
Forward P/E Ratio
26.81
Earnings per Share
$2.22
Earnings per Share Estimate Next Year
$3.52
Profit Margin
11.44%
Shares Outstanding
493,244,000
Percent Owned by Insiders
0.14%
Percent Owned by Institutions
66.96%
52-Week High
$97.98
52-Week Low
$69.21

Technical Indicators for Alcon AG

50-Day Moving Average
$92.47
200-Day Moving Average
$84.01
RSI
51.32
1.43

Analyst Ratings for Alcon AG

Strong Buy
16
Buy
6
Hold
4
Sell
1
Strong Sell
1

News About Alcon AG

Aug 27, 2024, 6:42 PM EST
We recently compiled a list of the Oppenheimer's Favorite Stocks For Next 12 Months: Top 32 Stock Picks. See more.
Aug 21, 2024, 8:11 AM EST
Alcon, Inc. See more.
Aug 21, 2024, 4:52 AM EST
Shares of Alcon (SIX:ALCC) fell after the company reported its second quarter results, which missed analyst expectations for both revenue and EBIT margin. See more.
Aug 20, 2024, 6:00 PM EST
For the quarter ended June 2024, Alcon (ALC) reported revenue of $2.48 billion, up 3.3% over the same period last year. See more.
Aug 20, 2024, 4:30 PM EST
Record Q2 2024 sales of $2.5 billion, up 3%, or 6% constant currency1 (cc) Q2 2024 diluted EPS of $0.45, up 32%, or 47% cc; core diluted EPS2 of $0.74, up 7%, or 15% cc H1 2024 cash from operations of $871 million; free cash flow3 of $667 million, up $478 million, or 253% Received U.S. See more.